MENU
NRIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nurix Therapeutics (NRIX) Ownership - Who owns Nurix Therapeutics?

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases... Show more

Profile

Industry
N/A
Address
1600 Sierra Point Parkway
Phone
+1 415 660-5320
Employees
317
Web
https://www.nurixtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.75B
P/E Ratio
N/A
Total Cash
540.73M
Projected Growth
N/A
Total Debt
58.66M
Revenue
71.78M
Risk (Beta)
2.44
Dividend Yield
N/A
Total Cash/Share
5.23
Total Debt/Equity
N/A
Revenue/Share
0.77 USD as % of share price
View a ticker or compare two or three
NRIX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1600 Sierra Point Parkway
Phone
+1 415 660-5320
Employees
317
Web
https://www.nurixtx.com